U.S. Markets closed

Cytosorbents Corporation (CTSO)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.30+0.20 (+4.88%)
At close: 4:00PM EDT
People also watch
AEMDELTPADXSONCSTTNP
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue9,527.8434,791.6164,122.825
Cost of Revenue3,953.7252,212.5462,133.888
Gross Profit5,574.1182,579.071,988.937
Operating Expenses
Research Development4,783.4913,871.0692,431.759
Selling General and Administrative11,097.9646,922.5155,553.167
Non Recurring1,184.7881,089.145896.847
Others---
Total Operating Expenses---
Operating Income or Loss-11,492.125-9,303.659-6,892.836
Income from Continuing Operations
Total Other Income/Expenses Net-533.495838.014-2,504.454
Earnings Before Interest and Taxes-12,257.425-8,456.344-9,707.314
Interest Expense---
Income Before Tax-12,257.425-8,456.344-9,707.314
Income Tax Expense-318.55-324.606-385.642
Minority Interest---
Net Income From Continuing Ops-11,938.875-8,131.738-9,321.672
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-11,938.875-8,131.738-9,321.672
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-11,938.875-8,131.738-18,588.345